Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    WS08 - Joint IASLC-CSCO-CAALC Session: Liquid Biopsy in Oncogene Driven NSCLC (On-demand)

    • 21:00 - 23:59
    • 8/06/2022
    • Location: On-Demand
    • Not for CME Credit
    • Type: Workshop
    • Track: N/A
    • +

      Session Moderator

      21:00 - 21:00  |  Presenter: Yi-Long Wu

      • Abstract

      Loading...

    • +

      Session Moderator

      21:00 - 21:00  |  Presenter: Chunxue Bai

      • Abstract

      Loading...

    • +

      Session Moderator

      21:00 - 21:00  |  Presenter: Caicun Zhou

      • Abstract

      Loading...

    • +

      Session Moderator

      21:00 - 21:00  |  Presenter: Karen Kelly

      • Abstract

      Loading...

    • +

      WS08.01 - Session Introduction

      21:00 - 21:02  |  Presenter: Yi-Long Wu

      • Abstract

      Loading...

    • +

      WS08.02 - Session Introduction

      21:02 - 21:04  |  Presenter: Chunxue Bai

      • Abstract

      Loading...

    • +

      WS08.03 - Session Introduction

      21:04 - 21:07  |  Presenter: Caicun Zhou

      • Abstract

      Loading...

    • +

      WS08.04 - Session Introduction

      21:07 - 21:10  |  Presenter: Karen Kelly

      • Abstract

      Loading...

    • +

      WS08.05 - Minimal Residual Disease (MRD) Negative: Potential for Cure in Resected Oncogene Driven NSCLC? Chinese Perspective

      21:10 - 21:30  |  Presenter: Jia-Tao Zhang

      • Abstract

      Loading...

    • +

      WS08.06 - Could MRD Change Our Clinical Practice? North American Perspective

      21:30 - 21:50  |  Presenter: Aadel Chaudhuri

      • Abstract

      Loading...

    • +

      WS08.07 - How to Use Liquid Biopsy to Monitor Treatment Efficacy for Advanced Driven NSCLC

      21:50 - 22:10  |  Presenter: Jie Hu

      • Abstract

      Loading...

    • +

      WS08.08 - Liquid Biopsy for Advanced Oncogene Driven NSCLC. European Perspective

      22:10 - 22:30  |  Presenter: Martin Filipits

      • Abstract

      Loading...

    • +

      WS08.09 - Sintilimab versus Pembrolizumab as Monotherapy or in Combination with Chemotherapy for Treatment Naïve Metastatic Non-small Cell Lung Cancer

      22:30 - 22:40  |  Presenter: Si-Yang Maggie Liu

      • Abstract

      Loading...

    • +

      WS08.10 - Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study

      22:40 - 22:50  |  Presenter: Xuxinyi Ling

      • Abstract

      Loading...

    • +

      WS08.11 - Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis

      22:50 - 23:00  |  Presenter: Yun Fan

      • Abstract

      This abstract is currently under embargo and will be released during the conference.

    • +

      WS08.12 - Discussant for Oral Abstracts

      23:00 - 23:20  |  Presenter: Sai-Hong Ignatius Ou

      • Abstract

      Loading...

    • +

      WS08.13 - Activity of aPD1-MSLN-CART Cells Against Metastatic Lung Cancer in a Phase 1 Trial

      23:20 - 23:21  |  Presenter: Xiaorong Dong

      • Abstract

      Loading...

    • +

      WS08.14 - Final Analyses of ALTER-L018: A Randomized Phase II Trial of Anlotinib Plus Docetaxel vs Docetaxel as 2nd-line Therapy for EGFR-Negative NSCLC

      23:21 - 23:22  |  Presenter: Lin Wu

      • Abstract

      Loading...

    • +

      WS08.15 - Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Squamous NSCLC

      23:22 - 23:23  |  Presenter: Jun Zhao

      • Abstract

      Loading...

    • +

      WS08.16 - The Increase of Blood Intratumor Heterogeneity is Associated with Unfavorable Outcomes of ICIs Plus Chemotherapy in NSCLC

      23:23 - 23:24  |  Presenter: Juan Zhou

      • Abstract

      Loading...

    • +

      WS08.17 - Utilization of Tumor Mutational Profiling to Identify the Immunotherapy Response in Non-small Cell Lung Cancer

      23:24 - 23:25  |  Presenter: Wenbin Li

      • Abstract

      Loading...

    • +

      WS08.18 - Discussant for Poster 1 - 5

      23:25 - 23:40  |  Presenter: Xiaorong Dong

      • Abstract

      Loading...

    • +

      WS08.19 - Phase Il Trial of Neoadjuvant Tislelizumab with Chemotherapy for Resectable Stage IIB-III Non-small Cell Lung Cancer

      23:40 - 23:41  |  Presenter: Yao-Bin Lin

      • Abstract

      Loading...

    • +

      WS08.20 - Comprehensive Analysis of a Dendritic Cell Marker Genes Signature to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma

      23:41 - 23:42  |  Presenter: Yuan Li

      • Abstract

      Loading...

    • +

      WS08.21 - Immune Evolution of Metastases & Underlying Molecular Mechanisms in Non-small Cell Lung Cancer

      23:42 - 23:43  |  Presenter: Wen-Fang Tang

      • Abstract

      Loading...

    • +

      WS08.22 - Neoadjuvant Toripalimab Combination in Patients with Stage IIB-IIIB NSCLC: A Single-arm, Phase 2 Trial (Renaissance Study)

      23:43 - 23:44  |  Presenter: Shi Yan

      • Abstract

      Loading...

    • +

      WS08.23 - Transcriptomic Heterogeneity in Non-Small Cell Lung Cancer with Four Structure-Based EGFR-Mutation Subgroups

      23:44 - 23:45  |  Presenter: Shun Lu

      • Abstract

      Loading...

    • +

      WS08.24 - Discussant for Poster 6 - 10

      23:35 - 23:50  |  Presenter: Ming Fang Zhao

      • Abstract

      Loading...

  • +

    ES05 - Oncogenic Alterations and Beyond - Novel Treatments

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Hall C2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Caicun Zhou

      • Abstract

      Loading...

    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Maximilian Johannes Hochmair

      • Abstract

      Loading...

    • +

      ES05.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Caicun Zhou

      • Abstract

      Loading...

    • +

      ES05.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Maximilian Johannes Hochmair

      • Abstract

      Loading...

    • +

      ES05.03 - Targeting Rarer Events in Known Targets: EGFR Exon20 (EGFR, HER2)

      12:02 - 12:14  |  Presenter: Giannis Mountzios

      • Abstract

      Loading...

    • +

      ES05.04 - All You Need to Know About KRAS

      12:14 - 12:26  |  Presenter: Odd Terje Brustugun

      • Abstract

      Loading...

    • +

      ES05.05 - Antibody-Drug Conjugates - Where We Stand Today?

      12:26 - 12:38  |  Presenter: Bob T. Li

      • Abstract

      Loading...

    • +

      ES05.06 - HRD/DDR in Lung Cancer: Role and Therapeutic Implications

      12:38 - 12:50  |  Presenter: Lauren Averett Byers

      • Abstract

      Loading...

    • +

      ES05.07 - Live Q&A

      12:50 - 13:00

      • Abstract

      Loading...

  • +

    EP05.02 - Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
    • +

      EP05.02-021 - An Updated Analysis of Toripalimab and Platinum-Doublet Chemotherapy as Neoadjuvant Therapy for Potentially Resectable NSCLC

      Presenter: Yongchang Zhang

      • Abstract

      Loading...

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-014 - Tislelizumab versus Docetaxel in Previously Treated Advanced Non-Small Cell Lung Cancer: Final Analysis of RATIONALE-303

      Presenter: Caicun Zhou

      • Abstract

      Loading...

    • +

      EP08.01-035 - Personalized ctDNA Detection to Monitor Outcome and Predict Immunotherapy Benefit in Locally Advanced and Metastatic NSCLC

      Presenter: Guanghui Gao

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-064 - ASTRIS China: A Real-world Study of Osimertinib in Patients with EGFR T790M Positive Non-small-cell Lung Cancer (NSCLC)

      Presenter: Qing Zhou

      • Abstract

      Loading...

    • +

      EP08.02-171 - PRO-CTCAE Analysis of Mobocertinib in EGFR Exon 20 Insertion‒Positive Metastatic Non‒Small Cell Lung Cancer (NSCLC)

      Presenter: Rosario Garcia

      • Abstract

      Loading...

  • +

    EP16.01 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
    • +

      EP16.01-005 - Cilia-related mRNA Profile Predicts Clinical Response to PD-1 Blockade in Lung Adenocarcinoma

      Presenter: Guanghui Gao

      • Abstract

      Loading...

  • +

    PL03 - Plenary 3: Presidential Symposium - Top Rated Abstracts (Live Streamed Session)

    • 08:30 - 10:20
    • 8/08/2022
    • Location: Hall C1
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N/A
    • +

      PL03.09 - IMpower010:Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC

      Presenter: ENRIQUETA FELIP

      • Abstract

      Loading...